GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VNDA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Is Vanda Pharmaceuticals Inc. stock still a buy after falling -5.15% on Thursday?
(Updated on Apr 18, 2024)

Buy or Hold candidate since Apr 17, 2024 Loss -5.15% PDF

The Vanda Pharmaceuticals Inc. stock price fell by -5.15% on the last day (Thursday, 18th Apr 2024) from $5.24 to $4.97. During the last trading day the stock fluctuated 7.15% from a day low at $4.90 to a day high of $5.25. The price has fallen in 8 of the last 10 days but is still up by 1.02% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -20 million shares and in total, 4 million shares were bought and sold for approximately $19.05 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 13.44% during the next 3 months and, with a 90% probability hold a price between $4.50 and $5.96 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VNDA Signals & Forecast

The Vanda Pharmaceuticals Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.43 and $4.17. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, April 17, 2024, and so far it has fallen -5.15%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Vanda Pharmaceuticals Inc. stock

Vanda Pharmaceuticals Inc. finds support from accumulated volume at $4.92 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.350 between high and low, or 7.15%. For the last week, the stock has had daily average volatility of 6.46%.

Our recommended stop-loss: $4.68 (-5.74%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (VNDA) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Vanda Pharmaceuticals Inc. to open at $5.04, and during the day (based on 14 day Average True Range), to move between $4.60 and $5.34, which gives a possible trading interval of +/-$0.370 (+/-7.44%) up or down from last closing price. If Vanda Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 14.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.92 (1.01%) than the resistance at $5.05 (1.61%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Vanda Pharmaceuticals Inc. stock A Buy?

Vanda Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

Current score: 0.914 Hold/Accumulate Downgraded

Predicted Opening Price for Vanda Pharmaceuticals Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$5.04 ( 1.34%) $4.97

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VNDA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.39 8.38 %
R2 5.25 5.69 %
R1 5.17 4.03 %
Current price: 4.97
Support S1 4.90 -1.35 %
S2 4.82 -3.01 %
S3 4.69 -5.70 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 5.24 5.43 %
R1 5.05 1.61 %
Current price 4.97
Support S1 4.92 -1.01%
S2 4.07 -18.11%
S3 3.91 -21.33%

FAQ

What is the symbol for Vanda Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Vanda Pharmaceuticals Inc. is VNDA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Vanda Pharmaceuticals Inc. Stock?
Vanda Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

How to buy Vanda Pharmaceuticals Inc. Stock?
Vanda Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Vanda Pharmaceuticals Inc. Stock.

What's the current price of Vanda Pharmaceuticals Inc. Stock?
As of the end of day on the 2024-04-18, the price of an Vanda Pharmaceuticals Inc. (VNDA) share was $4.97.

What is the 52-week high and low for Vanda Pharmaceuticals Inc. Stock?
The 52-week high for Vanda Pharmaceuticals Inc. Stock is $7.00 and the 52-week low is $3.30.

What is the market capitalization of Vanda Pharmaceuticals Inc. Stock?
As of the 2024-04-18, the market capitalization of Vanda Pharmaceuticals Inc. is 301.497M.

When is the next earnings date for Vanda Pharmaceuticals Inc.?
The upcoming earnings date for Vanda Pharmaceuticals Inc. is May 01, 2024.
Click to get the best stock tips daily for free!

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals. Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatr... VNDA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT